Enanta Pharmaceuticals stock price
에난타 파머슈티컬스NASDAQ:ENTA · Nasdaq · HealthcareToday's signals · No active technical signal.
Signal details →Enanta Pharmaceuticals last closed at $12.60 (-2.78%) on 2026-10-05. Listed on Nasdaq. Trailing 12 months PER is -5.8×. Its overall grade ranks 448 of 741 stocks in Healthcare.
About this company
Enanta Pharmaceuticals last closed at $12.60 (-2.78%) on 2026-10-05. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall C+ · 448/741
Valuation grade B+
Related stocks
- AbbVieCustomer
과거 주요 로열티/협업 파트너로, Enanta의 C형간염 관련 수익과 연결된 핵심 고객·협력사
- Vertex PharmaceuticalsCompetitor
호흡기/항바이러스 및 질환 치료제 개발에서 파이프라인이 일부 겹치는 대표 경쟁사
- Gilead SciencesCompetitor
항바이러스 치료제 영역의 대형 경쟁사로, 감염질환 시장에서 직접 비교되는 기업
About Enanta Pharmaceuticals
- What technical signals does Enanta Pharmaceuticals (ENTA) have?
- Enanta Pharmaceuticals current technical signals: no active technical signal.
- Is Enanta Pharmaceuticals a cup-and-handle pattern?
- No. Enanta Pharmaceuticals has no valid Cup signal right now.
- What published figures are available for Enanta Pharmaceuticals?
- Market cap: $363.67M. Trailing 12 months PER: -5.8×. Latest quarter PBR: 3.63×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-06 dataset
Turn what you saw on this name into a strategy
Ask Q about Enanta Pharmaceuticals, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.